Sort
261,768 grants matching “gene therapy”
Novel Ligands that Selectively Desensitize alpha4beta nAChRs for Smoking Cessatio
$843,310Kenneth J Kellar · Georgetown University · U19 · FY2014 · DA
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
$843,283Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
HIV-2 latency and its reversal
$843,234Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2025 · AI
HIV-2 latency and its reversal
$843,234Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2024 · AI
Efficient and scalable microfluidic gene delivery to hematopoietic stem cells to treat blood diseases
$843,224Sewoon Han · Cellfe Inc. · R44 · FY2023 · HL
Hematology Training
$843,208Janis L Abkowitz · University Of Washington · T32 · FY2025 · HL
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
$843,185Allan Balmain · University Of California, San Francisco · U01 · FY2009 · CA
Decoding the Cell-specific Impact of Epigenomic and Alternative Splicing Regulation during T1D Progression
$843,179Shuibing Chen · Weill Medical Coll Of Cornell Univ · U01 · FY2025 · DK
Improved delivery of bNAbs for targeting CNS infection in infants
$843,177Jing Wen · University Of California Los Angeles · R01 · FY2024 · NS
Substance Use and Immunity in HIV+ Adolescents by Systems Biology
$843,141Li Yin · University Of Florida · R01 · FY2014 · DA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$843,113James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Integrative Omics as a Discovery Tool for Pulmonary Hypertension
$843,057Marlene Rabinovitch · Stanford University · R01 · FY2015 · HL
Endocannabinoids And The Control Of Cardiovascular Function
$843,054George Kunos · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
$842,916Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2019 · CA
Transcriptional Control of Neuroinflammation in Alzheimer's Disease
$842,864Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AG
Pharmacogenomics of Microtubule Targeting Agents
$842,864Deanna L Kroetz · University Of California, San Francisco · R01 · FY2018 · CA
Phase II clinical evaluation of Omnitram in neuropathic pain
$842,819Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2016 · DA
STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS
$842,815Guido Silvestri · Emory University · R37 · FY2017 · AI
Systems Genetics Analysis of Alzheimer's Disease-Related Sleep Loss and the Transition to Dementia
$842,743Catherine Cook Kaczorowski · Jackson Laboratory · R01 · FY2023 · AG
Biological Functions of Chromosomal Proteins
$842,732Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Chromosomal Proteins and Chromosomal Functions
$842,732Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Mechanisms of SIV suppression by CD8+ lymphocytes
$842,716Guido Silvestri · Emory University · R01 · FY2010 · AI
Role Of Monocytes In AIDS And As Targets For Antiviral Therapy
$842,606Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2010 · DE
Impact of Reproductive Aging On HIV Persistence and Inflammation
$842,593Sara Gianella Weibel · University Of California, San Diego · R56 · FY2021 · AI
High Density Cell Respirator (HDCR) for the production of vectors, viruses and vaccines
$842,585Nicole Bergman · Xdemics Corporation · R42 · FY2021 · TR